secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001753926-25-001606
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Pelthos Therapeutics posts corporate presentation; no specific material updates disclosed
--------------------------------------------------------------------------------

- Corporate presentation for Q4 2025 made available on company website on October 14, 2025.
- No financial results, guidance, or product-specific updates provided in the filing text.
- The exhibit text is truncated, precluding identification of any material developments.
- Presentation furnished under Regulation FD and not incorporated by reference into SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625001606/0001753926-25-001606-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000175392625001606/g084975_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-001606

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer